Page 19 - GTM-4-1

Global Translational Medicine Advancements in cardiac regenerative therapy

19. Hamad S, Derichsweiler D, Papadopoulos S, et al. doi: 10.1007/s10565-023-09797-7
Generation of human induced pluripotent stem cell- 29. Burridge PW, Matsa E, Shukla P, et al. Chemically defined
derived cardiomyocytes in 2D monolayer and scalable 3D generation of human cardiomyocytes. Nat Methods.
suspension bioreactor cultures with reduced batch-to-batch 2014;11(8):855-860.
variations. Theranostics. 2019;9(24):7222-7238.
doi: 10.1038/nmeth.2999
doi: 10.7150/thno.32058
30. Burridge PW, Li YF, Matsa E, et al. Human induced
20. Ma J, Guo L, Fiene SJ, et al. High purity human- pluripotent stem cell-derived cardiomyocytes recapitulate
induced pluripotent stem cell-derived cardiomyocytes: the predilection of breast cancer patients to doxorubicin-
Electrophysiological properties of action potentials induced cardiotoxicity. Nat Med. 2016;22(5):547-556.
and ionic currents. Am J Physiol Heart Circ Physiol.
2011;301(5):H2006-H2017. doi: 10.1038/nm.4087
doi: 10.1152/ajpheart.00694.2011 31. Garbern JC, Lee RT. Mitochondria and metabolic transitions
in cardiomyocytes: Lessons from development for stem cell-
21. Kiss E, Fischer C, Sauter JM, Sun J, Ullrich ND. The structural derived cardiomyocytes. Stem Cell Res Ther. 2021;12(1):177.
and the functional aspects of intercellular communication
in IPSC-Cardiomyocytes. Int J Mol Sci. 2022;23(8):4460. doi: 10.1186/s13287-021-02252-6
doi: 10.3390/ijms23084460 32. Zhao MT, Shao NY, Garg V. Subtype-specific cardiomyocytes
for precision medicine: Where are we now? Stem Cells.
22. Li X, Zeng D, Chen Y, et al. Role of alpha‐and beta‐ 2020;38(7):822-833.
adrenergic receptors in cardiomyocyte differentiation
from murine‐induced pluripotent stem cells. Cell Prolif. doi: 10.1002/stem.3178
2016;50(1):e12310. 33. Zhou Y, Zhou R, Huang W, et al. Gene expression,
doi: 10.1111/cpr.12310 morphology, and electrophysiology during the dynamic
development of human induced pluripotent stem cell-
23. Liang P, Lan F, Lee AS, et al. Drug screening using a derived atrial- and ventricular-like cardiomyocytes.
library of human induced pluripotent stem cell-derived Biologics. 2024;18:115-127.
cardiomyocytes reveals disease-specific patterns of
cardiotoxicity. Circulation. 2013;127(16):1677-1691. doi: 10.2147/btt.s448054
doi: 10.1161/circulationaha.113.001883 34. Shiti A, Arbil G, Shaheen N, Huber I, Setter N, Gepstein L.
Utilizing human induced pluripotent stem cells to study
24. Lemmens M, Perner J, Potgeter L, et al. Identification of atrial arrhythmias in the short QT syndrome. J Mol Cell
marker genes to monitor residual iPSCs in iPSC-derived Cardiol. 2023;183:42-53.
products. Cytotherapy. 2022;25(1):59-67.
doi: 10.1016/j.yjmcc.2023.08.003
doi: 10.1016/j.jcyt.2022.09.010
35. Joshi J, Albers C, Smole N, Guo S, Smith SA. Human induced
25. Cho S, Lee C, Skylar-Scott MA, Heilshorn SC, Wu JC. pluripotent stem cell-derived cardiomyocytes (iPSC-CMs)
Reconstructing the heart using iPSCs: Engineering strategies for modeling cardiac arrhythmias: Strengths, challenges and
and applications. J Mol Cellu Cardiol. 2021;157:56-65. potential solutions. Front Physiol. 2024;15:1475152.
doi: 10.1016/j.yjmcc.2021.04.006 doi: 10.3389/fphys.2024.1475152
26. Yamamoto T, Sato Y, Yasuda S, et al. Correlation between 36. Seibertz F, Rubio T, Springer R, et al. Atrial fibrillation-
genetic abnormalities in induced pluripotent stem Cell- associated electrical remodelling in human induced
Derivatives and abnormal tissue formation in tumorigenicity pluripotent stem cell-derived atrial cardiomyocytes: A
tests. Stem Cells Transl Med. 2022;11(5):527-538. novel pathway for antiarrhythmic therapy development.
doi: 10.1093/stcltm/szac014 Cardiovasc Res. 2023;119(16):2623-2637.
27. Ye C, Yang C, Zhang H, et al. Canonical Wnt signaling doi: 10.1093/cvr/cvad143
directs the generation of functional human PSC-derived 37. Cyganek L, Tiburcy M, Sekeres K, et al. Deep phenotyping
atrioventricular canal cardiomyocytes in bioprinted cardiac of human induced pluripotent stem cell-derived atrial and
tissues. Cell Stem Cell. 2024;31(3):398-409.e5. ventricular cardiomyocytes. JCI Insight. 2018;3(12):e99941.
doi: 10.1016/j.stem.2024.01.008 doi: 10.1172/jci.insight.99941
28. Wang F, Yin L, Zhang W, Tang Y, Wang X, Huang C. The 38. Li J, Wiesinger A, Fokkert L, et al. Modeling the
method of sinus node-like pacemaker cells from human atrioventricular conduction axis using human pluripotent
induced pluripotent stem cells by BMP and Wnt signaling. stem cell-derived cardiac assembloids. Cell Stem Cell.
Cell Biol Toxicol. 2023;39(6):2725-2741. 2024;31:1667-1684.e6.

Volume 4 Issue 1 (2025) 11 doi: 10.36922/gtm.5745